NLG919
CAS: 1402836-58-1
Ref. 3D-FN137701
| 25mg | Ausgelaufen | ||
| 50mg | Ausgelaufen | ||
| 100mg | Ausgelaufen | ||
| 250mg | Ausgelaufen | ||
| 500mg | Ausgelaufen |
Produktinformation
Name:
NLG919
Beschreibung:
NLG919 is a small molecule that inhibits the enzyme IDO1, which is responsible for the breakdown of tryptophan. This inhibition results in increased levels of tryptophan and increased production of tumor necrosis factor-α (TNF-α), which has been shown to have significant cytotoxicity on prostate cancer cells. NLG919 also has potential to be an immunotherapy agent, as it induces antibodies against tumor cells. The proposed mechanism of action for NLG919 is based on its ability to inhibit IDO1 and TNF-α production, which can lead to tumor regression.
Hinweis:
Unsere Produkte sind nur für Laborzwecke. Für jede andere Verwendung, bitte melden sie sich bei uns.
Marke:
Biosynth
Langzeitlagerung:
Hinweise:
Chemische Eigenschaften
Molekulargewicht:
282.38 g/mol
Formel:
C18H22N2O
Reinheit:
Min. 95%
Farbe/Form:
Solid
InChl:
InChI=1S/C18H22N2O/c21-18(13-6-2-1-3-7-13)10-16-14-8-4-5-9-15(14)17-11-19-12-20(16)17/h4-5,8-9,11-13,16,18,21H,1-3,6-7,10H2
InChI Key:
InChIKey=YTRRAUACYORZLX-UHFFFAOYSA-N
SMILES:
OC(CC1c2ccccc2-c2cncn21)C1CCCCC1
MDL:
Schmelzpunkt:
Siedepunkt:
Flammpunkt:
Dichte:
Konzentration:
EINECS:
Merck:
HS-Code:
